Pages with the fewest revisions
Appearance
Showing below up to 50 results in range #601 to #650.
- Loratadine (2 revisions)
- Albuterol (2 revisions)
- Docusate (2 revisions)
- Cholecalciferol (2 revisions)
- Flibanserin (2 revisions)
- Turmeric (2 revisions)
- Finasteride (2 revisions)
- Glipizide (2 revisions)
- Omeprazole (2 revisions)
- Phenotype:NUDT15 intermediate metabolizer (2 revisions)
- Olopatadine (2 revisions)
- Phenotype:UGT1A1 poor metabolizer (2 revisions)
- Ergocalciferol (2 revisions)
- Ipratropium (2 revisions)
- Tretinoin (2 revisions)
- Brexanolone (2 revisions)
- Fexofenadine (2 revisions)
- Mupirocin (2 revisions)
- Insulin Glargine (2 revisions)
- Benazepril (2 revisions)
- Western licorice (2 revisions)
- Simvastatin (2 revisions)
- Olmesartan (2 revisions)
- Amoxicillin (2 revisions)
- Phenotype:CYP3A4 intermediate metabolizer (2 revisions)
- Phenotype:CYP2C19 poor metabolizer (2 revisions)
- Cyanocobalamin (2 revisions)
- Mometasone (2 revisions)
- Verapamil (2 revisions)
- Colchicine (2 revisions)
- Galcanezumab (2 revisions)
- Pravastatin (2 revisions)
- Atorvastatin (2 revisions)
- Sucralfate (2 revisions)
- Riboflavin (2 revisions)
- Phentermine (2 revisions)
- Phenotype:NUDT15 normal metabolizer (2 revisions)
- Phenotype:CYP2C9 poor metabolizer (2 revisions)
- Meloxicam (2 revisions)
- TiHKAL (2 revisions)
- Ivermectin (2 revisions)
- Acetaminophen (2 revisions)
- Hydrocortisone (2 revisions)
- Celecoxib (2 revisions)
- Yerba mate (2 revisions)
- Sodium Bicarbonate (2 revisions)
- Adalimumab (2 revisions)
- Chlorthalidone (2 revisions)
- Insulin Degludec (2 revisions)
- Cephalexin (2 revisions)